RUNX2 and congenital bilateral aplasia of vas deferens from CFTR mutation: H19 can inhibit the binding of transcription factor p53 to the promoter region of Notch1, upregulating the expression of the calcification-promoting genes BMP2 and RUNX2 by inhibiting the Notch1 signaling pathway and promoting the occurrence of CAVD (38).